Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute for Breathing and Sleep (IBAS) is a premier Australian research organization specializing in respiratory and sleep medicine. Based at Austin Health in Melbourne, the institute functions as a specialized clinical research organization (CRO) and academic hub, conducting high-impact clinical trials and translational research. IBAS focuses on improving diagnostic and treatment outcomes for conditions such as obstructive sleep apnea, COPD, and asthma through multidisciplinary collaboration. The organization partners with global pharmaceutical and medical device companies to evaluate novel therapies and technologies while also driving independent academic research. IBAS is recognized for its contribution to international clinical guidelines and its commitment to education and health promotion in the respiratory field.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute for Breathing and Sleep.